{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:09:17Z","timestamp":1786975757512,"version":"build-2736575974"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The ability to predict neurodevelopmental impairment (NDI) for infants diagnosed with hypoxic ischemic encephalopathy (HIE) is important for parental guidance and clinical treatment as well as for stratification of patients for future neurotherapeutic studies.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To examine the effect of erythropoietin on plasma inflammatory mediators in infants with moderate or severe HIE and to develop a panel of circulating biomarkers that improves the projection of 2-year NDI over and above the clinical data available at the time of birth.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This study is a preplanned secondary analysis of prospectively collected data from infants enrolled in the High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) Trial, which tested the efficacy of erythropoietin as an adjunctive neuroprotective therapy to therapeutic hypothermia. The study was conducted at 17 academic sites comprising 23 neonatal intensive care units in the United States between January 25, 2017, and October 9, 2019, with follow-up through October 2022. Overall, 500 infants born at 36 weeks\u2019 gestation or later with moderate or severe HIE were included.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Erythropoietin treatment 1000 U\/kg\/dose on days 1, 2, 3, 4 and 7.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Plasma erythropoietin was measured in 444 infants (89%) within 24 hours after birth. A subset of 180 infants who had plasma samples available at baseline (day 0\/1), day 2, and day 4 after birth and either died or had 2-year Bayley Scales of Infant Development III assessments completed were included in the biomarker analysis.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The 180 infants included in this substudy had a mean (SD) gestational age of 39.1 (1.5) weeks, and 83 (46%) were female. Infants who received erythropoietin had increased concentrations of erythropoietin at day 2 and day 4 compared with baseline. Erythropoietin treatment did not alter concentrations of other measured biomarkers (eg, difference in interleukin [IL] 6 between groups on day 4: \u22121.3 pg\/mL; 95% CI, \u22124.8 to 2.0 pg\/mL). After adjusting for multiple comparisons, we identified 6 plasma biomarkers (C5a, interleukin [IL] 6, and neuron-specific enolase at baseline; IL-8, tau, and ubiquitin carboxy-terminal hydrolase-L1 at day 4) that significantly improved estimations of death or NDI at 2 years compared with clinical data alone. However, the improvement was only modest, increasing the AUC from 0.73 (95% CI, 0.70-0.75) to 0.79 (95% CI, 0.77-0.81;\n P<\/jats:italic>\n \u2009=\u2009.01), corresponding to a 16% (95% CI, 5%-44%) increase in correct classification of participant risk of death or NDI at 2 years.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this study, erythropoietin treatment did not reduce biomarkers of neuroinflammation or brain injury in infants with HIE. Circulating biomarkers modestly improved estimation of 2-year outcomes.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT02811263<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.22131","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T11:31:42Z","timestamp":1688729502000},"page":"e2322131","source":"Crossref","is-referenced-by-count":33,"title":["Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy"],"prefix":"10.1001","volume":"6","author":[{"given":"Sandra E.","family":"Juul","sequence":"first","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Voldal","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan A.","family":"Comstock","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An N.","family":"Massaro","sequence":"additional","affiliation":[{"name":"Children\u2019s National Health Systems, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo K.","family":"Bammler","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis E.","family":"Mayock","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Heagerty","sequence":"additional","affiliation":[{"name":"University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne W.","family":"Wu","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Numis","sequence":"additional","affiliation":[{"name":"University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HEAL consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaashif","family":"Ahmad","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Baserga","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Bendel-Stenzel","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Benninger","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Chalak","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeun","family":"Chang","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Flibotte","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lampland","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Maitre","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mathur","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Merhar","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Mietzsch","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Poindexter","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Rao","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Riley","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Smyser","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Sokol","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisa","family":"Van Meurs","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joern-Hendrik","family":"Weitkamp","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Yanowitz","sequence":"additional","affiliation":[{"name":"for the HEAL consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"zoi230656r1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fneur.2015.00198","article-title":"Therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy\u2014where to from here?","volume":"6","author":"Davidson","year":"2015","journal-title":"Front Neurol"},{"key":"zoi230656r2","doi-asserted-by":"publisher","first-page":"c363","DOI":"10.1136\/bmj.c363","article-title":"Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data.","volume":"340","author":"Edwards","year":"2010","journal-title":"BMJ"},{"issue":"9","key":"zoi230656r3","doi-asserted-by":"publisher","first-page":"e1273","DOI":"10.1016\/S2214-109X(21)00264-3","article-title":"Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh.","volume":"9","author":"Thayyil","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"15","key":"zoi230656r4","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1056\/NEJMcps050929","article-title":"Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.","volume":"353","author":"Shankaran","year":"2005","journal-title":"N Engl J Med"},{"issue":"9460","key":"zoi230656r5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S0140-6736(05)17946-X","article-title":"Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial.","volume":"365","author":"Gluckman","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"zoi230656r6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Cooling for newborns with hypoxic ischaemic encephalopathy.","volume":"2013","author":"Jacobs","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"zoi230656r7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpeds.2011.08.004","article-title":"Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop.","volume":"159","author":"Higgins","year":"2011","journal-title":"J Pediatr"},{"issue":"5","key":"zoi230656r8","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1542\/peds.2010-2972A","article-title":"Pediatric basic and advanced life support: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations.","volume":"126","author":"Kleinman","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"zoi230656r9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa2119660","article-title":"Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns.","volume":"387","author":"Wu","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi230656r10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000486820","article-title":"High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): a randomized controlled trial\u2014background, aims, and study protocol.","volume":"113","author":"Juul","year":"2018","journal-title":"Neonatology"},{"issue":"2","key":"zoi230656r11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.","volume":"1","author":"Schulz","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"issue":"4","key":"zoi230656r12","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058552","article-title":"Race and ethnicity reporting and representation in pediatric clinical trials.","volume":"151","author":"Brewster","year":"2023","journal-title":"Pediatrics"},{"issue":"3","key":"zoi230656r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06445","article-title":"Comparison of multiplex cytokine assays in a pediatric cohort with epilepsy.","volume":"7","author":"Numis","year":"2021","journal-title":"Heliyon"},{"issue":"4","key":"zoi230656r14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jpeds.2008.04.013","article-title":"An algorithm for identifying and classifying cerebral palsy in young children.","volume":"153","author":"Kuban","year":"2008","journal-title":"J Pediatr"},{"issue":"4","key":"zoi230656r15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/dmcn.1997.39.issue-4","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy.","volume":"39","author":"Palisano","year":"1997","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"zoi230656r16","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure.","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"issue":"1","key":"zoi230656r17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/rssb.1996.58.issue-1","article-title":"Regression shrinkage and selection via the lasso.","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc B"},{"issue":"3","key":"zoi230656r18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/EDE.0000000000001340","article-title":"Instability of variable-selection algorithms used to identify true predictors of an outcome in intermediate-dimension epidemiologic studies.","volume":"32","author":"Cadiou","year":"2021","journal-title":"Epidemiology"},{"issue":"4","key":"zoi230656r19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1214\/20-STS815","article-title":"In defense of the indefensible: a very naive approach to high-dimensional inference.","volume":"36","author":"Zhao","year":"2021","journal-title":"Stat Sci"},{"issue":"3","key":"zoi230656r20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"11","key":"zoi230656r21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1109\/LSP.2014.2337313","article-title":"Fast implementation of DeLong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves.","volume":"21","author":"Sun","year":"2014","journal-title":"IEEE Signal Proc Let"},{"issue":"2","key":"zoi230656r22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-022962","article-title":"Predictive models of neurodevelopmental outcomes after neonatal hypoxic-ischemic encephalopathy.","volume":"147","author":"Peeples","year":"2021","journal-title":"Pediatrics"},{"issue":"8","key":"zoi230656r23","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.STR.0000173406.04891.8c","article-title":"Neonatal hypoxia\/ischemia is associated with decreased inflammatory mediators after erythropoietin administration.","volume":"36","author":"Sun","year":"2005","journal-title":"Stroke"},{"key":"zoi230656r24","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/561494","article-title":"The role of cytokines and inflammatory cells in perinatal brain injury.","volume":"2012","author":"McAdams","year":"2012","journal-title":"Neurol Res Int"},{"key":"zoi230656r25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpeds.2017.10.060","article-title":"Plasma biomarkers of brain injury in neonatal hypoxic-ischemic encephalopathy.","volume":"194","author":"Massaro","year":"2018","journal-title":"J Pediatr"},{"key":"zoi230656r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103605","article-title":"Early biomarkers of hypoxia and inflammation and two-year neurodevelopmental outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial.","volume":"72","author":"Wood","year":"2021","journal-title":"EBioMedicine"},{"issue":"5","key":"zoi230656r27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/pr.2015.280","article-title":"Association of brain injury and neonatal cytokine response during therapeutic hypothermia in newborns with hypoxic-ischemic encephalopathy.","volume":"79","author":"Orrock","year":"2016","journal-title":"Pediatr Res"},{"issue":"3","key":"zoi230656r28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jpeds.2013.10.067","article-title":"Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy.","volume":"164","author":"Chalak","year":"2014","journal-title":"J Pediatr"},{"issue":"12","key":"zoi230656r29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/jp.2016.132","article-title":"Cytokine changes in newborns with therapeutic hypothermia after hypoxic ischemic encephalopathy.","volume":"36","author":"Moon","year":"2016","journal-title":"J Perinatol"},{"key":"zoi230656r30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jpeds.2020.06.078","article-title":"Plasma and cerebrospinal fluid candidate biomarkers of neonatal encephalopathy severity and neurodevelopmental outcomes.","volume":"226","author":"Dietrick","year":"2020","journal-title":"J Pediatr"},{"issue":"6","key":"zoi230656r31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s41390-021-01405-w","article-title":"Serial plasma biomarkers of brain injury in infants with neonatal encephalopathy treated with therapeutic hypothermia.","volume":"90","author":"McGowan","year":"2021","journal-title":"Pediatr Res"},{"issue":"10","key":"zoi230656r32","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/jcbfm.2012.83","article-title":"Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy.","volume":"32","author":"Jenkins","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"zoi230656r33","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.616734","article-title":"Therapeutic hypothermia inhibits the classical complement pathway in a rat model of neonatal hypoxic-ischemic encephalopathy.","volume":"15","author":"Shah","year":"2021","journal-title":"Front Neurosci"},{"issue":"22","key":"zoi230656r34","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1523\/JNEUROSCI.0525-17.2017","article-title":"Complement C5aR1 signaling promotes polarization and proliferation of embryonic neural progenitor cells through PKC?.","volume":"37","author":"Coulthard","year":"2017","journal-title":"J Neurosci"},{"key":"zoi230656r35","doi-asserted-by":"publisher","first-page":"15096","DOI":"10.1038\/ncomms15096","article-title":"Developmental activities of the complement pathway in migrating neurons.","volume":"8","author":"Gorelik","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"zoi230656r36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4049\/jimmunol.2200540","article-title":"Complement: the road less traveled.","volume":"210","author":"Kemper","year":"2023","journal-title":"J Immunol"},{"key":"zoi230656r37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1742-2094-9-137","article-title":"Complement activation in the injured central nervous system: another dual-edged sword?","volume":"9","author":"Brennan","year":"2012","journal-title":"J Neuroinflammation"},{"issue":"16","key":"zoi230656r38","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury.","volume":"35","author":"Brennan","year":"2015","journal-title":"J Neurosci"},{"key":"zoi230656r39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fneur.2012.00144","article-title":"Biomarkers of hypoxic-ischemic encephalopathy in newborns.","volume":"3","author":"Douglas-Escobar","year":"2012","journal-title":"Front Neurol"},{"issue":"8","key":"zoi230656r40","first-page":"714","article-title":"Blood neuronal specific enolase in newborns with perinatal asphyxia.","volume":"32","author":"Verd\u00fa P\u00e9rez","year":"2001","journal-title":"Rev Neurol"},{"issue":"7","key":"zoi230656r41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/PCC.0000000000000155","article-title":"Biomarkers S100B and neuron-specific enolase predict outcome in hypothermia-treated encephalopathic newborns.","volume":"15","author":"Massaro","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"4930","key":"zoi230656r42","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1126\/science.2530630","article-title":"The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.","volume":"246","author":"Wilkinson","year":"1989","journal-title":"Science"},{"key":"zoi230656r43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2014.04.007","article-title":"Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer\u2019s disease.","volume":"570","author":"Schmidt","year":"2014","journal-title":"Neurosci Lett"},{"issue":"4","key":"zoi230656r44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system.","volume":"101","author":"Binder","year":"1985","journal-title":"J Cell Biol"},{"key":"zoi230656r45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2018.12.013","article-title":"Prognostic value of electroencephalography in hypothermia-treated neonates with hypoxic-ischemic encephalopathy: a meta-analysis.","volume":"93","author":"Han","year":"2019","journal-title":"Pediatr Neurol"},{"issue":"6","key":"zoi230656r46","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ejpn.2016.06.003","article-title":"Role of EEG background activity, seizure burden and MRI in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischaemic encephalopathy in the era of therapeutic hypothermia.","volume":"20","author":"Weeke","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"zoi230656r47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ejpn.2018.09.001","article-title":"Electroencephalography and brain magnetic resonance imaging in asphyxia comparing cooled and non-cooled infants.","volume":"23","author":"De Wispelaere","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"zoi230656r48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00247-017-3893-y","article-title":"A validated clinical MRI injury scoring system in neonatal hypoxic-ischemic encephalopathy.","volume":"47","author":"Trivedi","year":"2017","journal-title":"Pediatr Radiol"},{"key":"zoi230656r49","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-023-02510-8","article-title":"How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?","author":"Wu","year":"2023","journal-title":"Pediatr Res"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2807057\/juul_2023_oi_230656_1688055915.99744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T11:31:51Z","timestamp":1688729511000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2807057"}},"subtitle":["A Secondary Analysis of the HEAL Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.22131","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}